Inventor · disambiguated record
Fanying Meng
Also filed as: MENG FANYING
10 granted patents·16 pending applications·98 citations·filing 2001–2023
88Inventor score
Files withASCENTAWITS PHARMACEUTICALS LTD10TELIK INC6TONGWEI SOLAR CHENGDU CO LTD4SANWA KAGAKU KENKYUSHO CO2THRESHOLD PHARMACEUTICALS INC2
Top patents by PatentIndex Score
26 records- 0188US6506739B1Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agentsTELIK INC·Filed 2001·Granted Jan 14, 2003·26 cites·20 claims
- 0282US7297696B2Antagonists of MCP-1 function and methods of use thereofTELIK INC·Filed 2004·Granted Nov 20, 2007·18 cites·33 claims
- 0380US6962926B2Antagonist of MCP-1 function, and compositions and methods of use thereofSANWA KAGAKU KENKYUSHO CO·Filed 2003·Granted Nov 8, 2005·17 cites·20 claims
- 0480US6670364B2Antagonists of MCP-1 function and methods of use thereofTELIK INC·Filed 2002·Granted Dec 30, 2003·14 cites·65 claims
- 0577US6677365B2Antagonists of MCP-1 function and methods of use thereofTELIK INC·Filed 2002·Granted Jan 13, 2004·11 cites·40 claims
- 0675US6809113B2Antagonists of MCP-1 function and methods of use thereofTELIK INC·Filed 2002·Granted Oct 26, 2004·8 cites·40 claims
- 0765US9254299B2Administration of hypoxia activated prodrugs in combination with Chk1 inhibitors for treating cancerTHRESHOLD PHARMACEUTICALS INC·Filed 2012·Granted Feb 9, 2016·1 cites·13 claims
- 0864US6998407B2Antagonists of MCP-1 function and methods of use thereofSANWA KAGAKU KENKYUSHO CO·Filed 2003·Granted Feb 14, 2006·2 cites·24 claims
- 0962US6992086B2Antagonists of MCP-1 function and methods of use thereofTELIK INC·Filed 2003·Granted Jan 31, 2006·1 cites·26 claims
- 1054US2025295677A1Method for treating cancer by using th-302 alone or in combination with parp inhibitorASCENTAWITS PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 1153US2023347575A1Photosensitive polyimide resin for ultraviolet (uv) curing-based 3d printing and preparation method thereofUNIV SHAANXI TECHNOLOGY·Filed 2023·Application pending·0 cites
- 1249US2023339991A1Hypoxia-activated dna alkylating agent and medical use thereofASCENTAWITS PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1349US2025186468A1Method for treating patient with brca-mutated cancerASCENTAWITS PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 1448US2024162364A1Transparent conductive oxide film and heterojunction solar cellTONGWEI SOLAR CHENGDU CO LTD·Filed 2021·Application pending·0 cites
- 1547US2024316079A1Use of akr1c3-activated compoundOBI PHARMA INC·Filed 2021·Application pending·0 cites
- 1646US12453190B2Method for preparing heterojunction solar cell, heterojunction solar cell and application thereofTONGWEI SOLAR CHENGDU CO LTD·Filed 2022·Granted Oct 21, 2025·0 cites·10 claims
- 1746US2025387419A1Parp inhibitor-resistant patient treated with th-302ASCENTAWITS PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 1846US2023026163A1Anticancer compound and medical use thereofASCENTAWITS PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1945US2025344550A1Heterojunction solar cell, preparation method thereof and power generation deviceTONGWEI SOLAR CHENGDU CO LTD·Filed 2022·Application pending·0 cites
- 2045US2015005262A1Hypoxia activated prodrugs and mtor inhibitors for treating cancerTHRESHOLD PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 2143US2024204118A1Solar cell and manufacturing method thereofTONGWEI SOLAR CHENGDU CO LTD·Filed 2022·Application pending·0 cites
- 2242US2025281514A1Treatment of cancer patients having kras mutationsASCENTAWITS PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 2341US2024142453A1Akr1c3 detection method, and diagnostic kit for detecting akr1c3 and use thereofASCENTAWITS PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 2440US2024368209A1Gemcitabine anticancer derivative and anticancer pharmaceutical useASCENTAWITS PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 2536US2022251021A1Akr1c3 inhibitor and medical useASCENTAWITS PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 2626US2021283151A1Use of compound in drug for preventing, treating, or alleviating painASCENTAWITS PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fanying Meng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →